Product Description: Prafnosbart (DS-6016A) is an IgG1-kappa, anti-ACVR1 (activin A receptor type 1, ACVRLK2, ALK2, ACVR1A, SKR1) humanized monoclonal antibody. Prafnosbart can be used for bone metabolism disorders research[1].
Applications: Metabolism-protein/nucleotide metabolism
Formula: N/A
References: [1]International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 36, No. 2, 2022.
CAS Number: 2566473-71-8
Molecular Weight: N/A
Research Area: Metabolic Disease
Solubility: H2O
Target: Others